Zai Lab's (HKG:9688) net loss narrowed to $41.7 million in the third quarter from $69.2 million in the year-ago period, according to a Tuesday filing with the Hong Kong stock exchange.
Loss per share at the biopharmaceutical company narrowed to $0.04 from $0.07 in the previous year.
Revenue grew 47% to $101.8 million from $69.2 million a year earlier.
Shares of the company fell 8% Wednesday morning in Hong Kong.
Price (HKD): $23.35, Change: $-1.1, Percent Change: -4.50%
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。